Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 


NMDA receptor antagonist
BML-EA104-0005 5 mg 122.00 USD
Do you need bulk/larger quantities?
Replaces Prod. #: ALX-550-033

Active form of AP5. Potent NMDA receptor antagonist.

Product Details

Alternative Name:D(-)-2-Amino-5-phosphopentanoic acid
Purity:≥99% (HPLC)
Identity:Determined by 1H-NMR.
Appearance:White to off-white solid.
Solubility:Soluble in water (acidify for better solubility).
Shipping:Ambient Temperature
Long Term Storage:Ambient
Use/Stability:Store, as supplied, at room temperature for up to 1 year. Store solutions at -20°C for up to 3 months.
Handling:Protect from light.
Regulatory Status:RUO - Research Use Only
Please mouse over

Product Literature References

The NMDA receptor antagonist D-2-amino-5-phosphonopentanoate (D-AP5) impairs spatial learning and LTP in vivo at intracerebral concentrations comparable to those that block LTP in vitro: S. Davis et al.; J. Neurosci. 12, 21 (1992), Abstract;
Structural, conformational, and stereochemical requirements of central excitatory amino acid receptors: J.J. Hansen & P. Krogsgaard-Larsen; Med. Res. Rev. 10, 55 (1990), Abstract;
Actions of D and L forms of 2-amino-5-phosphonovalerate and 2-amino-4-phosphonobutyrate in the cat spinal cord: J. Davies & C. Watkins; Brain Res. 235, 378 (1982), Abstract;
The effects of a series of omega-phosphonic alpha-carboxylic amino acids on electrically evoked and excitant amino acid-induced responses in isolated spinal cord preparations: R.H. Evans et al.; Br. J. Pharmacol. 75, 65 (1982), Abstract;
2-Amino-5-phosphonovalerate (2APV), a potent and selective antagonist of amino acid-induced and synaptic excitation: J. Davies et al.; Neurosci. Lett. 21, 77 (1981), Abstract;
Activity of the enantiomers of 2-amino-5-phosphono-valeric acid as stereospecific antagonists of excitatory aminoacids: T.W. Stone et al.; Neuroscience 6, 2249 (1981), Abstract;
Excitatory amino acid transmitters: J.C. Watkins et al.; Annu. Rev. Pharmacol. Toxicol. 21, 165 (1981), Abstract;

Related Literature

Download as PDF

All new literature pieces